Published in BMJ on March 19, 1994
Patients' action during their cardiac event: qualitative study exploring differences and modifiable factors. BMJ (1998) 7.00
Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris. BMJ (1994) 4.49
Call to needle times after acute myocardial infarction in urban and rural areas in northeast Scotland: prospective observational study. BMJ (1998) 3.20
Attitudes of general practitioners to prehospital thrombolysis. BMJ (1994) 2.75
What should be the general practitioner's role in early management of acute myocardial infarction? Br J Gen Pract (1995) 2.38
Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care. Heart (2000) 2.01
Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics. BMJ (2003) 1.99
Suspected myocardial infarction and the GP. BMJ (1994) 1.94
Safety and efficacy of nurse initiated thrombolysis in patients with acute myocardial infarction. BMJ (2002) 1.74
The primary care workforce crisis: a time for decisive action. Br J Gen Pract (1997) 1.71
Multi-purpose HealthCare Telemedicine Systems with mobile communication link support. Biomed Eng Online (2003) 1.71
Trends in the provision of thrombolytic treatment between 1993 and 1997. Myocardial Infarction Audit Group. Heart (1999) 1.67
Reduction in treatment delay by paramedic ECG diagnosis of myocardial infarction with direct CCU admission. Heart (1997) 1.64
Thrombolysis in acute myocardial infarction: the safety and efficiency of treatment in the accident and emergency department. J Accid Emerg Med (1999) 1.57
Aspirin and acute myocardial infarction: clarifying the message. Br J Gen Pract (1995) 1.48
Impact of a public campaign on pre-hospital delay in patients reporting chest pain. Heart (1996) 1.47
Resuscitation by general practitioners. Br J Gen Pract (1997) 1.33
Assessment of the practicality and safety of thrombolysis with anistreplase given by general practitioners. Br J Gen Pract (1995) 1.32
Out-of-hospital cardiac arrest due to coronary heart disease: a comparison of survival before and after the introduction of defribrillators in ambulances. Heart (1996) 1.15
Some reservations about clinical guidelines. Arch Dis Child (1995) 1.13
The management of acute myocardial infarction. Postgrad Med J (1995) 1.13
Pre-hospital delay in patients with acute coronary syndrome: factors associated with patient decision time and home-to-hospital delay. Eur J Cardiovasc Nurs (2008) 1.07
One-year prospective study of cases of suspected acute myocardial infarction managed by urban and rural general practitioners. Br J Gen Pract (1996) 0.97
Pre-hospital aspirin for suspected myocardial infarction and acute coronary syndromes: a headache for paramedics? Emerg Med J (2001) 0.97
Practice policies for responding to patients with chest pain. Br J Gen Pract (1994) 0.96
Audit of prehospital thrombolysis by general practitioners in peripheral practices in Grampian. Heart (1998) 0.96
Emergency care in general practice. Should be properly recognised. BMJ (1995) 0.95
Delay between the onset of symptoms of acute myocardial infarction and seeking medical assistance is influenced by left ventricular function at presentation. Br Heart J (1995) 0.94
Acute myocardial infarction. Br J Gen Pract (1995) 0.93
Thrombolysis, the general practitioner, and the electrocardiogram. Br Heart J (1994) 0.89
Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group. Br Heart J (1995) 0.89
Performance Evaluation of an Enhanced Uplink 3.5G System for Mobile Healthcare Applications. Int J Telemed Appl (2008) 0.88
Nine-year comparison of presentation and management of acute coronary syndromes in Ireland: a national cross-sectional survey. BMC Cardiovasc Disord (2005) 0.88
A new performance indicator for acute myocardial infarction. Heart (2001) 0.87
Balancing proactive and reactive care. Occas Pap R Coll Gen Pract (1995) 0.81
Thrombolysis after acute myocardial infarction. J Accid Emerg Med (1997) 0.80
A report of a working group of the BCS: cardiology in the district hospital. Br Heart J (1994) 0.79
Primary care telemedicine in the UK. Br J Gen Pract (1997) 0.78
Evaluation of a paired creatine kinase test for the diagnosis of acute myocardial infarction in patients with a non-diagnostic electrocardiogram. J Accid Emerg Med (1997) 0.78
Setting up a heart emergency centre. Postgrad Med J (1997) 0.75
Acute myocardial infarction. Br J Gen Pract (1995) 0.75
Early management of myocardial infarction. Confirm diagnosis before giving thrombolytic treatment. BMJ (1994) 0.75
Acute myocardial infarction. Br J Gen Pract (1995) 0.75
Early management of myocardial infarction. Paramedics should give an opiate. BMJ (1994) 0.75
Call to needle times after acute myocardial infarction. Delay in calling for help for chest pain. BMJ (1999) 0.75
Early management of myocardial infarction. Senior staff should see all emergencies. BMJ (1994) 0.75
Impact of "dual response" on prehospital thrombolysis in remote and rural areas of Scotland: prospective observational study. Emerg Med J (2004) 0.75
Does a single bolus thrombolytic reduce door to needle time in a district general hospital? Emerg Med J (2004) 0.75
Early management of mycardial infarction. Presentation is often pain free in elderly patients. BMJ (1994) 0.75
Emergency care in general practice. British Heart Foundation recommends early defibrillation. BMJ (1995) 0.75
Aspirin and suspected myocardial infarction: a life-saving treatment we too often forget. J Accid Emerg Med (1995) 0.75
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet (1988) 10.64
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 5.73
Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis. BMJ (1992) 5.58
Patient and general practitioner delays in acute myocardial infarction. Br Med J (Clin Res Ed) (1988) 4.94
Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J (1989) 4.62
"Heartstart Scotland"--initial experience of a national scheme for out of hospital defibrillation. BMJ (1991) 4.56
Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA (1993) 4.36
General practitioners' use of electrocardiography: relevance to early thrombolytic treatment. BMJ (1989) 3.48
Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction. Lancet (1993) 3.43
Nalbuphine analgesia in the prehospital setting. Am J Emerg Med (1988) 2.56
Treatable arrhythmias in cardiac arrests seen outside hospital. Lancet (1992) 2.46
Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J (1992) 2.46
Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J (1990) 2.17
Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J (1990) 2.14
Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11
Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol (1990) 1.95
Patients with suspected myocardial infarction: effect of mode of referral on admission time to a coronary care unit. Br J Gen Pract (1992) 1.92
Delays to thrombolysis in the treatment of myocardial infarction. J R Coll Physicians Lond (1993) 1.75
The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects. J Clin Invest (1974) 1.49
Audit of an emergency ambulance service: impact of a paramedic system. J R Coll Physicians Lond (1992) 1.46
Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction. Eur Heart J (1992) 1.33
Pre-hospital thrombolysis: current status and future prospects. J R Coll Physicians Lond (1991) 1.31
Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable? Circulation (1993) 1.28
Aspirin and fibrinolysis in acute myocardial infarction: meta-analytic evidence for synergy. J Clin Epidemiol (1991) 1.13
Out-of-hospital, paramedic administered streptokinase for acute myocardial infarction. Lancet (1988) 1.13
Aspirin does not improve early arterial patency after streptokinase treatment for acute myocardial infarction. Br Heart J (1993) 1.06
Arterial oxygen tension in acute myocardial infarction. Serial analysis of clinical state and blood gas changes. Am Heart J (1970) 1.06
Planning a pre-hospital cardiac resuscitation programme: an analysis of community and system factors in London. J R Coll Physicians Lond (1989) 1.05
Resuscitation training for cardiac patients and their relatives--its effect on anxiety. Resuscitation (1992) 1.04
Delay in admitting patients with chest pain. Br J Gen Pract (1991) 1.01
A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction. Br Heart J (1989) 1.01
A coronary-care unit in the routine management of acute myocardial infarction. Lancet (1967) 11.31
Natural history of acute coronary heart attacks. A community study. Br Heart J (1972) 8.55
Problems in evaluating coronary care units. Their responsibilities and their relation to the community. Am J Cardiol (1967) 3.70
A milestone for myocardial infarction. BMJ (1988) 3.42
Ventricular fibrillation complicating acute myocardial infarction. Lancet (1968) 2.80
Treatable arrhythmias in cardiac arrests seen outside hospital. Lancet (1992) 2.46
Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet (1973) 2.04
Natural history of unstable angina. Lancet (1972) 2.03
Observations on cardiac arrythmias during laparoscopy. Br Med J (1972) 2.02
Oral mexiletine in high-risk patients after myocardial infarction. Lancet (1981) 1.91
Sick sinus syndrome: experience of a cardiac pacemaker clinic. Br Med J (1974) 1.86
Early neurological complications of coronary artery bypass surgery. Br Med J (Clin Res Ed) (1985) 1.78
Artificial pacing in management of complete heart block complicating acute myocaerdial infarction. Br Med J (1968) 1.71
Prognosis of new and worsening angina pectoris. Br Med J (1976) 1.59
Infective endocarditis: a survey of cases in the South-East region of Scotland, 1969-72. Thorax (1976) 1.59
Comparison of arrhythmia computer and conventional monitoring in coronary-care unit. Lancet (1975) 1.55
Task Force Report: The legal implications of medical guidelines--a Task Force of the European Society of Cardiology. Eur Heart J (1999) 1.47
Pharmacokinetics of lidocaine in man. Clin Pharmacol Ther (1971) 1.45
Plasma-levels of lignocaine after intramuscular injection. Lancet (1968) 1.44
The apex beat. Ir Med J (1991) 1.38
Long-term treatment of ventricular arrhythmias with oral mexiletine. Am Heart J (1976) 1.36
"Stress" hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes? Lancet (1983) 1.33
Controlled trial of sotalol for one year after myocardial infarction. Lancet (1982) 1.32
Arrhythmias and cellular electrophysiological changes during myocardial "ischaemia" and reperfusion. Cardiovasc Res (1983) 1.26
Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. Lancet (1975) 1.25
The agonising negative trend in monitoring of clinical trials. Lancet (1999) 1.25
Beta blockers after myocardial infarction: have trials changed practice? Br Med J (Clin Res Ed) (1984) 1.25
Coronary care and the community. Ann Intern Med (1968) 1.21
Role of the pharmaceutical industry in major clinical trials. Lancet (1987) 1.20
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation (1989) 1.19
Complete bundle-branch block complicating acute myocardial infarction. N Engl J Med (1970) 1.16
Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery. Stroke (1987) 1.16
Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol (2000) 1.15
Mortality in acute upper gastrointestinal haemorrhage: a six-year survey from the University Hospital of Wales. Postgrad Med J (1981) 1.15
Early intellectual dysfunction following coronary bypass surgery. Q J Med (1986) 1.13
Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J (1981) 1.13
Bundle-branch block in acute myocardial infarction. Br Heart J (1965) 1.09
"Reciprocal" depression of the ST segment in acute myocardial infarction. Br Med J (Clin Res Ed) (1983) 1.09
Smoking and coronary artery bypass surgery. Br Heart J (1994) 1.07
Neuro-ophthalmological complications of coronary artery bypass graft surgery. Acta Neurol Scand (1987) 1.06
Hemodynamic effects of artificial pacing in complete heart block complicating acute myocardial infarction. Circulation (1968) 1.06
Ventricular arrhythmias in syndrome of balloon deformity of mitral valve. Definition of possible high risk group. Br Heart J (1976) 1.04
Retroperitoneal fibrosis associated with metoprolol. Br Med J (Clin Res Ed) (1982) 1.04
High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol (1995) 1.03
Myocardial infarction with normal coronary arteries and factor XII deficiency. Br Heart J (1985) 0.99
The history of coronary care units. Br Heart J (1987) 0.98
The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc Res (1995) 0.98
Endogenous prostaglandins, adenosine 3':5'-monophosphate and sodium transport across isolated frog skin. J Physiol (1976) 0.98
Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology (1999) 0.97
Coronary microangiography in the guinea pig, rabbit and ferret. Int J Cardiol (1984) 0.97
Arrhythmogenic and electrophysiological effects of alpha adrenoceptor stimulation during myocardial ischaemia and reperfusion. J Mol Cell Cardiol (1987) 0.94
Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. Circulation (1990) 0.93
Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol (1987) 0.93
An analysis of factors predisposing to neurological injury in patients undergoing coronary bypass operations. Q J Med (1989) 0.92
The incidence and significance of early pericardial effusion after open heart surgery. Eur J Cardiothorac Surg (1987) 0.91
Platelet counts and aggregates in coronary artery disease. Eur Heart J (1982) 0.91
Aortic coarctation associated with aortic or mitral valve disease: which lesion to correct first? Ann Thorac Surg (1998) 0.90
Antiarrhythmic and electrophysiological effects of alpha adrenoceptor blockade during myocardial ischaemia and reperfusion in isolated guinea-pig heart. J Mol Cell Cardiol (1985) 0.90
Adenosine causes transient dilatation of coronary arteries in man. Br J Clin Pharmacol (1987) 0.90
Maintenance of the inotropic effect of digoxin on long-term treatment. Br Med J (Clin Res Ed) (1982) 0.90
Thrombolysis, the general practitioner, and the electrocardiogram. Br Heart J (1994) 0.89
Long-term intellectual dysfunction following coronary artery bypass graft surgery: a six month follow-up study. Q J Med (1987) 0.89
The deleterious effects of myocardial catecholamines on cellular electrophysiology and arrhythmias during ischaemia and reperfusion. Eur Heart J (1984) 0.89
Kinetics of smooth muscle cell proliferation and intimal thickening in a pig carotid model of balloon injury. Atherosclerosis (1995) 0.88
Relationship between trace elements, sugar consumption, and taste in Crohn's disease. Gut (1983) 0.88
Peripartum cardiomyopathy. Prog Cardiovasc Dis (1985) 0.87
Plasma adenosine concentrations during adenosine-induced respiratory stimulation in man. Eur J Clin Pharmacol (1991) 0.87
Long term treatment of ventricular arrhythmias with oral mexiletine. Postgrad Med J (1977) 0.87
The practical implications of the coronary artery surgery trials. Br Heart J (1985) 0.87
Effects of myocardial catecholamine depletion on cellular electrophysiology and arrhythmias during ischaemia and reperfusion. Cardiovasc Res (1984) 0.86
Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration. Lancet (1977) 0.86
The significance and management of ventricular arrhythmias. The Bradshaw Lecture 1979. J R Coll Physicians Lond (1980) 0.86
Bilateral bundle-branch block complicating acute myocardial infarction. Lancet (1971) 0.85
Experience of a rapid access acute chest pain clinic. Ir Med J (1997) 0.85
A microcomputer system for real-time analysis of cardiac action potentials. J Med Eng Technol (1983) 0.85
The evolution of the coronary care unit. Cardiovasc Res (2001) 0.85
Methods for the control of diabetes after acute myocardial infarction. Diabetes Care (1985) 0.84
Measuring the effect of a mobile coronary care unit upon the community. Br Heart J (1979) 0.84
SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation (1993) 0.84
Toward preventing coronary death from ventricular fibrillation. Circulation (1976) 0.84
Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction. J Cardiovasc Pharmacol (1980) 0.83
Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplasty. Cardiovasc Res (1992) 0.83
Neurological complications of coronary artery bypass graft surgery: six month follow-up study. Br Med J (Clin Res Ed) (1986) 0.82
Ventricular arrhythmias after acute myocardial infarction treated with procainamide or mexiletine. Postgrad Med J (1977) 0.81
Tolerance to glyceryl trinitrate patches: prevention by intermittent dosing. Br Med J (Clin Res Ed) (1987) 0.81
Prospective randomized trial of single clamp technique versus intermittent ischaemic arrest: myocardial and neurological outcome. Eur J Cardiothorac Surg (1998) 0.81
Comparisons and combinations in anti-anginal therapy. Eur Heart J (1985) 0.81
Cardiorespiratory response to exercise before and after acute beta-adrenoreceptor blockade in nonsmokers and chronic smokers. Int J Cardiol (1986) 0.80
Effects of sotalol on arrhythmias and electrophysiology during myocardial ischaemia and reperfusion. Cardiovasc Res (1984) 0.79
Prevalence of inflammatory bowel disease amongst Mormons in Britain and Ireland. Soc Sci Med (1985) 0.79
Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT). Eur Heart J (1994) 0.79
Pacing for heart block in acute myocardial infarction. Ann N Y Acad Sci (1969) 0.79
Pacing in the management of bundle-branch block complicating acute myocardial infarction. Br Heart J (1969) 0.79
Effect of pentazocine on pulmonary circulation. Lancet (1972) 0.79
Acute myocardial infarction: are there missed opportunities for reperfusion? UK Heart Attack Study Investigators. Coron Artery Dis (1998) 0.78
Delayed ventricular depolarization--correlation with ventricular activation and relevance to ventricular fibrillation in acute myocardial infarction. Eur Heart J (1984) 0.78
The clinical pharmacology of antiarrhythmic drugs. Cardiovasc Clin (1984) 0.78